Fernando Moldenhauer

Fernando Moldenhauer

Auto-generated profile, based on publicly available information

Fernando Moldenhauer

Adult Down Syndrome Outpatient Clinic, Department of Internal Medicine, Instituto de Investigación Sanitaria-Princesa (IIS-IP), Hospital Universitario de La Princesa, Madrid, Spain

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
DADiego Real de Asua
Diego Real de Asua
MQMiriam Quero
Miriam Quero
FMFernando Moldenhauer
Fernando Moldenhauer
CSCarmen Suarez
Carmen Suarez

1 January 1991 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
PDF file
FGF. Garcia-Martin
F. Garcia-Martin
GAG. de Arriba
G. de Arriba
TCT. Carrascosa
T. Carrascosa
FMF. Moldenhauer
F. Moldenhauer
EME. Martin-Escobar
E. Martin-Escobar
FSF. Saiz
F. Saiz
Anticardiolipin antibodies are autoantibodies clinically associated with hypercoagulability. Systemic thrombosis and thrombosis of the vascular access for haemodialysis coexist with immunoregulation abnormalities in end-stage renal disease (ESRD). The aim of the present study was to analyse the incidence of thrombotic episodes and the presence of anticardiolipin antibodies and lupus anticoagulant in 73 patients with ESRD – 51 on haemodialysis and 22 on conservative treatment Four (18%) patients on conservative treatment had IgG-anticardiolipin, three of them also having lupus anticoagulant. Sixteen (31%) patients on haemodialysis showed IgG-anticardiolipin and 11 (22%) lupus anticoagulant; overall, 19 (37%) patients on haemodialysis had IgG-anticardiolipin and/or lupus anticoagulant. This greater incidence in haemodialysis was associated with a more frequent use of cuprophane membranes (68% versus 34%, P <0.05). Six patients with ESRD – one on conservative treatment – met criteria for the diagnosis of primary antiphospholipid syndrome, clinically characterised by thrombosis of the vascular access. IgG-anticardiolipin and/or lupus anticoagulant are frequently found in ESRD and their incidence increases with haemodialysis, probably due to some kind of membrane bioincompatibility. IgG-anticardiolipin and lupus anticoagulant can be associated with thrombotic episodes, being constituents of an ESRD-related antiphospholipid syndrome.

1 November 2014 in Research in Developmental Disabilities
Verified
Journal Article
Closed access
DADiego Real de Asua
Diego Real de Asua
PPPedro Parra
Pedro Parra
RCRamón Costa
Ramón Costa
FMFernando Moldenhauer
Fernando Moldenhauer
CSCarmen Suarez
Carmen Suarez

1 September 1987 in Arthritis & Rheumatism
Verified
Journal Article
Closed access
PDF file
FMF. Moldenhauer
F. Moldenhauer
JDJ. David
J. David
AFA. H. L. Fielder
A. H. L. Fielder
PLP. J. Lachmann
P. J. Lachmann
MWM. J. Walport
M. J. Walport

1 January 2014 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
DADiego Real de Asua
Diego Real de Asua
PPPedro Parra
Pedro Parra
RCRamón Costa
Ramón Costa
FMFernando Moldenhauer
Fernando Moldenhauer
CSCarmen Suarez
Carmen Suarez
Real de Asua D, et al. Diabetes Metab J. 2014 Dec;38(6):464-471. http://dx.doi.org/10.4093/dmj.2014.38.6.464

1 September 2019 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
JCJose Curbelo
Jose Curbelo
OROlga Rajas
Olga Rajas
BABelén Arnalich
Belén Arnalich
JGJosé María Galván-Román
José María Galván-Román
SLSergio Luquero-Bueno
Sergio Luquero-Bueno
JAJavier Aspa
Javier Aspa